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a b s t r a c t
Previous inﬂuenza pandemics (1918, 1957, and 1968) have all had multiple waves. The 2009 pandemic
inﬂuenza A (H1N1) (pandemic H1N1) started in April 2009 and was followed, in the United States (US)
and temperate Northern Hemisphere, by a second wave during the fall of 2009. The ratio of susceptible
and immune individuals in a population at the end of awave determines the potential andmagnitude of a
subsequentwave. As inﬂuenza vaccines are not completely protective, therewas a combined immunity in
the population at the beginning of 2010 (due to vaccination and due to previous natural infection), and it
wasuncertain if thismixture of herd immunitywas enough toprevent a thirdwaveof pandemic inﬂuenza
during the winter of 2010. Motivated by this problem, we developed a mathematical deterministic two-
group epidemic model with vaccination and calibrated it for the 2009 pandemic H1N1. Then, applying
methods from mathematical epidemiology we developed a scheme that allowed us to determine critical
thresholds for vaccine-induced and natural immunity thatwould prevent the spread of inﬂuenza. Finally,
we estimated the level of combined immunity in the US during winter 2010. Our results suggest that a
third wave was unlikely if the basic reproduction number R0 were below 1.6, plausible if the original R0
was 1.6, and likely if the original R0 was 1.8 or higher. Given that the estimates for the basic reproduction
number for pandemic inﬂuenza place it in the range between 1.4 and 1.6 (Bacaer and Ait Dads, 2011;
Fraser et al., 2009; Munayco et al., 2009; Pourbohloul et al., 2009; Tuite et al., 2010; White et al., 2009;
Yang et al., 2009), our approach accurately predicted the absence of a third wave of inﬂuenza in the US
during the winter of 2010. We also used this scheme to accurately predict the second wave of pandemic
inﬂuenza in London and the West Midlands, UK during the fall of 2009.ntroduction
In the past century, therewere threemajor inﬂuenza pandemics
1918, 1957, and 1968) and they all had multiple waves. There is
vidence of an early wave in the spring of 1918 in the United States
US) and Europe, followed by a large wave in the fall of 1918 and
third, more mild wave, in the winter of 1919 (Olson et al., 2005;
arry et al., 2008;He et al., 2011). In theUS and temperateNorthern
emisphere, 2009 inﬂuenza pandemic A (H1N1) (pandemic H1N1)
tarted in April 2009, and it was followed by a second wave during
he fall of 2009. The ratio of susceptible and immune individuals
n a population at the end of a given wave, plays a crucial role in
etermining the possibility and magnitude of the following wave.
hile vaccines were not available in the previous pandemics,
e now have the ability to produce vaccines quickly and in large
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uckman Drive, Gainesville, FL, 32611, USA. Tel.: +1 352 294 1938;
ax: +1 352 294 1930.
755-4365/$ – see front matter © 2011 Elsevier B.V. All rights reserved.
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quantities (WHO, 2009). In fact, more than 20 vaccines were
developed during late spring to early summer of 2009. In several
countries, vaccination started as early as mid-September and
continued during the fall of 2009, so that, at the end of the second
wave, a fraction of the population had acquired vaccine-induced
immunity, while some fraction of the population got infected and
hence acquired natural immunity. Since inﬂuenza vaccines are not
completely protective, vaccine-induced immunity is not expected
to be as strong as naturally acquired immunity due to natural
infection. Therefore, at the end of the second wave, the population
had a combination of natural and vaccine-induced immunity.
For logistical, practical, and economic reasons, estimating the
number of people infected and the number of people vaccinated
is not always possible. In the context of the H1N1 inﬂuenza pan-
demic, these estimates were extremely difﬁcult to make. It then
became important to determine if this mixture of immunity in
the population was going to be enough to prevent a third wave
of pandemic inﬂuenza. Motivated by this problem, we developed
a simple scheme to determine the possibility of a third wave of
pandemic inﬂuenza in the United States in the winter of 2010,
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ased on the level of herd immunity at that time. To do this, we
ormulated a mathematical model for pandemic inﬂuenza. Using
nowntechniques for computing thebasic reproductionnumberR0
nd the effective reproduction number Rf (deﬁned to be the repro-
uction number when a fraction f of the population is immune or
accinated) we determined critical thresholds of vaccine-induced
mmunity and of naturally induced immunity for preventing fur-
her spread of inﬂuenza virus. By combining these thresholds we
ere able to obtain lower and upper bounds of the level of com-
ined immunity in the population after the second wave of H1N1
nﬂuenza. This allowed us to correctly predict the absence of a third
ave of pandemic H1N1 inﬂuenza in the US. For comparison, we
nvestigated the occurrence of the second wave of pandemic H1N1
nﬂuenza in Englandduring the fall of 2009, using the same scheme.
his approach is easily generalizable and can be applied to other
nfectious diseases.
aterials and methods
Inﬂuenza has strong seasonality patterns in the temperate
orthern and Southern hemispheres, usually peaking during the
ate fall or early winter. In other regions of the world, the peaks
end to occur during the rainy season, but the seasonality is less
ronounced. The basic mechanisms for these changes are not com-
letely understood, but there is some evidence that survival and
ransmission of the inﬂuenza virus are inﬂuenced by physical fac-
ors, suchashumidityand temperature (Lowenetal., 2007;Schaffer
t al., 1976; Shaman et al., 2010; Soebiyanto et al., 2010). In addi-
ion, inﬂuenza spreads best during periods when schools are open.
he aim of our work is to predict the occurrence or absence of a
ew epidemic wave based on the current level of herd immunity.
or this reason,wewill assume, below, thatwe are at the beginning
f the inﬂuenza season, so that, in the absence of prior immunity
n the population, an epidemic wave is certain.
athematical model
Our inﬂuenza model is based on the standard SIR model, and it
s an extension of the model given in (Hill and Longini, 2003). We
onsidered a closed population of sizeN. Since the time scale for the
preadof inﬂuenza is short compared tomigrationordemographics
births anddeaths), none of these features are included.Wedivided
he population into two sub-populations of children and adults of
izeN1 andN2, so thatN=N1 +N2.Members in each group are either
usceptibles Sij, infectedasymptomaticAij, infected symptomatic Iij,
r recovered Rij, where i=1 indicates children, i=2 adults, while j
enotes the vaccination status (j=0 for the unvaccinated and j=1
or the vaccinated). The following assumptions were made:
A fraction  of the infected people will develop symptoms. The
infected asymptomatic people never develop symptoms but are
still able to transmit the infection to others. Infected asymp-
tomatic people have their infectiousness reduced by a factor m
compared to infected symptomatic people (Longini et al., 2004),
where m∈ [0, 1].
cik is the number of contacts per day between people in group i
and people in group k, where i, k∈ {1, 2}.
p is the probability of infection given contact; it will be used here
as a parameter to vary the transmissibility of the infection.
Children and adults recover at rates 1 and 2 respectively.
Following the ideas in (Halloran et al., 1997), we consider that
vaccination has three major effects in the vaccinee, as follows
(i) VES, the vaccine efﬁcacy for susceptibility is the ability of the
vaccine to prevent infection.demics 4 (2012) 22–32 23
(ii) VEI, thevaccineefﬁcacy for infectiousness (conditionedupon
being infected) is the effect of the vaccine on reducing infec-
tiousness.
(iii) VEP, thevaccineefﬁcacy forpathogenicity (conditionedupon
being infected), accounts for the effect of the vaccine on
reducing the probability of symptomatic disease given infec-
tion.
Based on these assumptions we have the following system of
differential equations:
Unvaccinated Vaccinated
dS10
dt
= −1S10 dS11
dt
= −1S11 (1)
dS20
dt
= −2S20 dS21
dt
= −2S21 (2)
dA10
dt
= 1(1 − )S10 − 1A10 dA11
dt
= 1(1 −  )S11 − 1A11 (3)
dA20
dt
= 2(1 − )S20 − 2A20 dA21
dt
= 2(1 −  )S21 − 2A21 (4)
dI10
dt
= 1S10 − 1I10 dI11
dt
= 1 S11 − 1I11 (5)
dI20
dt
= 2S20 − 2I20 dI21
dt
= 2 S21 − 2I21 (6)
dR10
dt
= 1(A10 + I10) dR11
dt
= 1(A11 + I11) (7)
dR20
dt
= 2(A20 + I20) dR21
dt
= 2(A21 + I21) (8)
where VES =1− , VEI =1− and VEP =1− . The forces of infec-
tion for children and adults, respectively, are given by
1 =
pc11
N1
(mA10 +mA11 + I10 + I11)
+ pc12
N2
(mA20 +mA21 + I20 + I21) (9)
and
2 =
pc21
N1
(mA10 +mA11 + I10 + I11)
+ pc22
N2
(mA20 +mA21 + I20 + I21) . (10)
Computation of the basic reproduction number
In this sectionwe follow the ideas of Hill and Longini (2003) and
Longini et al. (1998). Let f1 be the fraction of vaccinated children
and f2 be the fraction of vaccinated adults, where we assume that
vaccination occurred before the (possible) epidemic.
The basic reproduction number R0 for a given disease is deﬁned
as the expected number of secondary infections resulting from a
single typical infectious person in a completely susceptible popu-
lation, and Rf is deﬁned to be the effective reproduction number,
which is the reproduction number in the presence of vaccination.
We use the approach given in Diekmann et al. (1990), Brauer et al.
(2008), and van den Driessche and Watmough (2002) to compute
the next generationmatrixK and effective reproduction number Rf.
The details of this computation can be found in Appendix A.
If Rf >1, the epidemic will grow, whereas if Rf ≤1, the epidemic
will die out (Diekmann et al., 1990).We set Rf =1 as the threshold of
interest.Wenote that if f1 = f2 =0, thenno vaccination occurred, and
the effective reproduction number is in fact the basic reproduction
number, R0.
We assume natural infection confers complete protection
against reinfection, equivalent to setting  =0 in the vaccinated Eqs.
(1) and (2). So, tomodel the fraction of children and adultswhopre-
viously got the infection and who are now immune, we simply set
 =0 in our computations. We let Rn be the effective reproduction
number with natural immunity, that is, the effective reproduction
number when a fraction of the population has natural immunity
( =0).
24 L. Matrajt, I.M. Longini Jr. / Ep
Fig. 1. Surfaces representing all the eigenvalues of the next generation matrix for
R0 = 1.6. All the eigenvalues of the matrix but two are zero (plotted in yellow). The
ones that are non-zero are plotted above in red and blue. The green plot corresponds
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umber with vaccination, Rf(f1, f2). (For interpretation of the references to color in
his ﬁgure legend, the reader is referred to the web version of this article.)
cheme to determine the possibility of multiple epidemic waves
In this section, we outline the scheme we developed to investi-
ate the possibility of multiple inﬂuenza epidemic waves using the
odel and the thresholds established above. In the next section,
e will use this approach to predict the absence of a third wave of
andemic H1N1 inﬂuenza in the United States during thewinter of
010.
We begin by noting that if all the parameters of the model are
nown except for the values of f1 and f2, then Rf becomes a func-
ion of f1 and f2. We deﬁne Rf(f1, f2) as the effective reproduction
umber with a fraction f1 of vaccinated children and a fraction f2 of
accinated adults. Analogously, Rn(f1, f2) is the effective reproduc-
ion number with f1 of the children and f2 of the adults completely
mmune (due toprevious infection). The threshold condition is then
quivalent to ﬁnding the contour lines in the f1f2-planewhere Rf(f1,
2) = 1. For all thepoints above the curve = {f= (f1, f2) |Rf(f1, f2) = 1},
f <1 and the epidemic will not occur, while for points below the
urve , Rf >1 and the epidemicwill occur.While these curvesmay
ot be unique, they separate the f1f2-plane into connected regions
here either Rf <1 or Rf >1.
We deﬁne a critical vaccination vector to be a pair (f1, f2) such
hat Rf(f1, f2) = 1. Analogously,we deﬁne a critical immune vector to
e apair (f1, f2) such thatRn(f1, f2) = 1. The critical vaccination vector
ives us apair of fractions of each subpopulation that shouldbe vac-
inated such that no signiﬁcant transmission can occur. In addition,
he critical immune vector gives us a pair of those fractions of each
ubgroup that must be completely immune for no transmission to
ccur in the entire population.
In general, ﬁnding an analytical solution for the contour lines of
f(f1, f2) = 1 is difﬁcult, since we need to ﬁnd the roots of a polyno-
ial of degree eight. To overcome this problem, we use symbolic
r numeric software to compute the values of all the eigenvalues of
he next generation matrix K as a function of f1 and f2. In this fash-
on, we obtain surfaces representing all the different eigenvalues.
n example is given in Fig. 1. Plotting the surfaces can be helpful
hen a closed analytical form of the eigenvalues is not available,
ince this allows us to determine which eigenvalue has the largest
bsolute value. We then intersect the largest surface (correspond-
ng to the largest eigenvalue) with the plane P = {z = 1}. We graphidemics 4 (2012) 22–32
the contour lines of Rf and Rn for which Rf(f1, f2) = 1 and Rn(f1, f2) = 1
are satisﬁed, and by doing so we determine the critical vaccina-
tion vectors and the critical immune vectors. If the structure of
the problem allows it, one can ﬁnd explicit analytic solutions for
the eigenvalues of the matrix K, and hence explicitly compute the
contour lines. Once we have determined a way to compute these
contour lines, the analysis is carried out in three steps.
First,weassumethat theonlyway tobeprotected justbefore the
start of a new inﬂuenza season is to be vaccinated. We then com-
pute the critical vaccination vectors using the method described
above. In this fashion we obtain thresholds for the fraction of vac-
cinated children and adults needed to prevent a further epidemic
wave.While this is not realistic, since peoplewho got inﬂuenza in a
previouswavewould have some degree of protection, it permits us
to isolate the effects of vaccination from those of natural immunity
at the population level.
Second,we assume that the onlyway to be protected just before
the start of a new inﬂuenza season is to be naturally immune, that
is, to have acquired the infection in a previous wave. This scenario
will only be realistic if a vaccine for the particular inﬂuenza strain
did not exist, but, as before, it allows us to separate out the effects of
natural immunity. We then compute the critical immune vectors,
providing us with a threshold for the fraction of naturally immune
children and adults needed to prevent a further epidemic.
Finally, we combine this information to establish upper and
lower bounds for the threshold on the fractions of children and
adults, either vaccinated or naturally immune, that would prevent
a new wave of inﬂuenza. In this way, we predict the regions in the
f1f2−plane that would result in a third wave and the regions in the
plane thatwould prevent a thirdwave.We then compute estimates
of the number of children and adults infected and vaccinated, and
compare these estimates with our thresholds. If the estimates lie
above the thresholds, there is sufﬁcient combined herd immunity
to prevent a subsequent epidemic wave. If the estimates lie below
the threshold, a new epidemic wave is possible. If the estimate lies
between the lower and upper bound, then the method is inconclu-
sive. This approachwill be clariﬁed in thenext section,whenweuse
it to predict the absence of a third wave of pandemic inﬂuenza in
the United States during the winter 2009–2010, and to predict the
occurrence of the second wave of pandemic inﬂuenza in England
during the fall 2009.
Application: 2009 pandemic H1N1 inﬂuenza
Third wave in the United States
During the ﬁrst (Spring 2009) and second (Fall 2009) waves
of the pandemic H1N1, a signiﬁcant fraction of the population
got infected and became naturally immune. Meanwhile, several
vaccines were developed and during the second wave, a fraction
of children and adults got vaccinated. We used the model and
approach described above to accurately predict the absence of a
third wave of pandemic inﬂuenza in the United States during the
winter of 2010.
Model calibration
Based on current estimates (e.g. Balcan et al., 2009; Bacaer
and Ait Dads, 2011; Fraser et al., 2009; Munayco et al., 2009;
Pourbohloul et al., 2009; Tuite et al., 2010; White et al., 2009; Yang
et al., 2009),we consideredR0 for pandemicH1N1 to lie in the inter-
val [1.2, 1.8]. We used the parameter p to vary the intensity of the
infection by selecting values of p for which the original basic repro-
duction number would be in the range [1.2, 1.8]. We calibrated the
model (1)–(8) for the pandemicH1N1 epidemic in theUS according
to Table 2. Using Hill and Longini (2003) as a guide, we manually
L. Matrajt, I.M. Longini Jr. / Epi
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omputed the contact rates cij given in Table 1 so that the ﬁnal ill-
ess attack rates (deﬁned as the percentage of the population that
ecame ill with inﬂuenza) shown in Table 3 would match the ﬁnal
llness attack rates observed at the end of the second wave of pan-
emic inﬂuenza in the United States (Centers for Disease Control
nd Prevention, 2010a). These numbers satisfy the following three
onditions: ﬁrst, the number of contacts within the child group is
igher than the contacts between children and adults and within
he adult group. Secondly, the number of contacts in the diagonal
child-to-child and adult-to-adult) is higher than the off-diagonal
ontacts. This is in agreement with previously published contact
tudies (Wallinga et al., 2006; Mossong et al., 2008). Finally, the
atio of the illness attack rate in children to adults is similar to the
ne obtained from the CDC estimates (Centers for Disease Control
nd Prevention, 2010a). We further assumed symmetry in the con-
acts, i.e. cij = cji. While we acknowledge that this is a limitation of
ur model, we performed a thorough sensitivity analysis in these
arameters as shown below.
The numbers of previously infected or vaccinated people are
sed in our scheme to compute the effective reproductive num-
er. For this reason, we need to take into account all the people
ho became previously infected or were vaccinated against this
articular strain of inﬂuenza. This implies that we need to consider
he number of infected (or vaccinated) people that resulted from
oth the ﬁrst and the second waves of pandemic H1N1 in 2009.
he estimates for the ﬁnal attack rates provided by the CDC are
he cumulative numbers for the total number of people vaccinated
nd infected up to December 2009. This implies that these esti-
ates combine the attack rates of the ﬁrst and the second wave of
andemic H1N1, giving us the desired estimates.
We assumed that pandemic H1N1 vaccines have similar efﬁca-ies to theones for seasonal vaccines, andhencewe took thevaccine
fﬁcacies for susceptibility, infectiousness and pathogenicity as
n average between well-matched live attenuated vaccine and a
able 2
arameter values.
Parameter Description
1 Recovery rate for children
2 Recovery rate for adults
 Fraction of symptomatic
m Reduction of infectiousness for asymptomatics
c11, c12, c21, c22 Contact rates
VES , VEI , VEP Vaccine efﬁcacies for susceptibility, infectiousness and pathogenic
N Total population
Initially infected fraction of the population
Percentage of children under 18 (US)
a Computed as a weighted average from the rates given by Longini et al. (1978).
b Computed as a weighted average from the rates given by Longini et al. (1978).
c The contact rates were calculated to obtain the ﬁnal illness attack rates shown in Tab
able 3
inal illness attack rates for the range of basic reproduction numbers considered.
Value of p used R0 Overall illness attack rate
0.5885 1.2 12.2
0.6868 1.4 23.6
0.7850 1.6 31.8
0.8830 1.8 38.2
a These ﬁnal attack rates approximately match the attack rates published by Centers fodemics 4 (2012) 22–32 25
well-matched inactivated vaccine using the estimates given in
Basta et al. (2008).
Finding the eigenvalue surfaces
For each R0 in the range given above, we used symbolic soft-
ware (Mathematica) to obtain surfaces of the eigenvalues of the
next generationmatrixK as described in the previous section. Here,
the structure of our model resulted in a next generation matrix
of rank 2. This implies that zero is an eigenvalue of multiplicity
6 and we were able to compute closed analytic formulas for the
two non-zero eigenvalues. The explicit formulas can be found in
Appendix A.
Recall that this analysis is done in three steps. First, we assume
that the only way to be protected at the beginning of the inﬂuenza
season is by being vaccinated. For instance, Fig. 1 shows all the
eigenvalue surfaces in thepresenceofvaccination togetherwith the
plane P = {z = 1} and R0 =1.6. We determine the spectral radius of
thismatrixRf(f1, f2), as the largest of these surfaces, andnumerically
compute the contour lines for which Rf(f1, f2) = 1. These contour
lines are shown in Fig. 2. We will refer to these lines as the critical
vaccination curves. The points above this curve (the green region in
Fig. 2) correspond to coveragesof avaccinated fraction f1 of children
and a vaccinated fraction f2 of adults that will make the effective
reproduction number be below one, so that no further transmis-
sion of the infection would be possible. For example, if 60% of the
children and 10% of the adults were vaccinated during the second
wave, that would be enough to prevent a new epidemic wave. This
would also be true if 45% of the children and 75% of the adults were
vaccinated.
Then, we repeated this analysis to ﬁnd the critical immune
curves (here  =0). Under this scenario, the only way to be pro-
tected at the beginning of the inﬂuenza season is by being naturally
immune. An example of the critical immune curves for R0 =1.6, is
given in Fig. 3. For example, once 45% or more of children coupled
with 10% ormore of adults have already been infected, therewould
be no chance of transmission; or if 33% ormore of children immune
coupled with 75% or more of adults have previously been infectedSince inﬂuenza vaccines are not completely protective, the crit-
ical vaccination curves will always lie above the critical immune
curves. The threshold curve for a mixture of vaccination-induced
Value Reference
0.449 Longini et al. (1978)a
0.329 Longini et al. (1978)b
2/3 Longini et al. (2004) and Carrat et al. (2008)
0.5 Longini et al. (2004) and Cioﬁ degli Atti et al. (2008)
1,0.2, 0.2, 0.4 Calculatedc
ity 0.4, 0.45, 0.75 Basta et al. (2008)
200,000 Assumption
1 Assumption
24.16 US Census Bureau (2009)
le 3.
Illness attack rate in children (%) Illness attack rate in adults (%)
21.4 9.3
36.9 19.4a
45.9 27.3
51.8 33.9
r Disease Control and Prevention (2010a)
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infected during the previous wave and exactly y% of the chil-
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3nd adults naturally immune (people who became infected and recovered) by the
he reader is referred to the web version of this article.)
rotected for the next wave. However, we do not precisely
now the number of children who were infected during the
rst and second waves of pandemic H1N1 (spring and fall of
009) nor the number of children who were vaccinated dur-
ng the second wave (fall 2009). Moreover, we cannot guarantee
hat children who were vaccinated were not already immune,
specially given the fact that a fraction of the infected chil-
ren never develop symptoms. Therefore, we know that the
evel of protection of children should lie somewhere between
% and (x+ y)%. A similar analysis can be done for the adult age
roup.
We used this argument to estimate the level of combined
mmunity in children and adults in the winter 2010. First, we
btained raw estimates for the total number of people vacci-
ated and infected by using the information provided by the
DC (Centers for Disease Control and Prevention, 2010a). Then,
e used the data given by Ross et al. (2010) to calculate the
ge-speciﬁc infection attack rates in children and adults by com-
uting a weighted average of their estimates, where the weights
ere given by the proportions of the population in each age
roup according to US census data (U.S. Census Bureau, 2009).
e assumed that vaccination was carried out independently of
hether a person was previously infected or not. We considered
he full range of estimates given by the CDC in Centers for Disease
ontrol and Prevention (2010a), hence obtaining a rectangle S in
he f1f2−plane of estimates of combined immunity at the end
f winter 2009–2010 for children and adults, shown as a dotted
ox in Fig. 4. The center of this rectangle, corresponding to the
ean of the estimates, gives the combined immune and vacci-
ated fraction of children to be about 54% and for adults to be about
7%.f the ﬁrst wave. (For interpretation of the references to color in this ﬁgure legend,
Predicting the absence of a third wave of pandemic H1N1
Given an estimate for the level of combined immunity in winter
2010, wewere able to correctly predict the absence of a third wave
of pandemic H1N1. To do this, we looked at the estimated level
of combined immunity together with the intermediate regions.
The results are shown in Fig. 4. Provided that the rectangle S lies
on or above the intermediate regions, the effective reproduction
numbers will be below one and there will be no further trans-
mission. The rectangle S lies above the intermediate regions for
R0 =1.2, and R0 =1.4. According to our model, this implies that a
third epidemic wave would not have occurred for these reproduc-
tion numbers. However, for R0 =1.6, the rectangle S overlaps with
the intermediate region, and our model suggests that a third wave
would have been possible. Finally, if the original R0 were 1.8 or
higher, our results suggest that substantial spreadwould have been
possible.
Therewas no thirdwave of pandemic inﬂuenza in the US during
thewinter of 2010. Considering thatmost of the estimates forR0 for
pandemic H1N1 place it at 1.6 or below (Bacaer and Ait Dads, 2011;
Fraser et al., 2009; Munayco et al., 2009; Pourbohloul et al., 2009;
Tuite et al., 2010; White et al., 2009; Yang et al., 2009), our method
correctly predicted the absence of this new epidemic wave.
Second wave in London and the West Midlands
For comparison, we present in this section an analogous analy-
sis for the secondwave of pandemic H1N1 inﬂuenza in London and
theWestMidlands, UK. Contrary to theUS, theUK and in particular,
England, experienced a big ﬁrst epidemic wave of pandemic H1N1
inﬂuenza during the summer of 2009 (Health Protection Agency,
2009). This provides a unique opportunity for us to investigate
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Fig. 6. Sensitivity analysis for the contact rates. For each run, the values of the contact rates were taken from a uniform distribution of length 0.2, centered at the value of the
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iij used. The contact rates were taken independently but only the triplets that gave
nd c11 > c22 were considered. The results are generally robust under this sensitivity
pidemic wave is very unlikely. For R0 = 1.6, most of the curves intersect the rectan
ith the rectangle or lie above the rectangle, indicating that a third wave would be
hether ourmethod canpredict the occurrence of the secondwave
f pandemic H1N1 inﬂuenza in the fall of 2009, in the UK.
The main parameters of the model calibrated for the US epi-
emic do not change for the epidemic in England (contact rates,
accine efﬁcacies, etc.), so we only adjusted the proportion of
hildren and adults in the population so that they matched the
roportions in the UK. Since vaccine was introduced in the UK dur-
ng the second wave, we only need to consider natural immunity,
cquired through infection during the ﬁrst wave (spring-summer
009).Weused thedata for Londonand theWestMidlandsofMiller
t al. (2010) to estimate the fraction of the children and the adults
ho became infected during the ﬁrst wave in this region. Miller
t al. (2010) partitioned the population into eight age groups (0–4,
–14, 15–24, 25–44, 45–64, 65–74, 75–79, and ≥80years), so we
onsidered children to beup to 24years old. The fraction of children
reviously infected was computed as a weighted average, where
he weights corresponded to the proportion of the population in
ach age group in the UK (U.S. Census Bureau, 2011). We consid-
red the full range of estimates given inMiller et al. (2010). In their
aper, they found that there was no difference between the base-
ine (before the ﬁrst wave of pandemic H1N1) and September 2009
or people in the older age groups (25years and older). We then
ssumed that there were no adults immune after the ﬁrst wave of
1N1 in London and the West Midlands.
The results are presented in Fig. 5. The estimate of the natu-
al immunity in the children population in London and the West
idlands is shown in red. For R0 =1.2, the estimate for the natural
mmunity lies above the critical immune curve. OurmethodwouldR0 < 1.25, or 1.35<R0 < 1.45, or 1.55<R0 < 1.65 or 1.75<R0 < 1.85 and where c11 > c12
ng as R0 < 1.6, all the runs lie below the dotted rectangle, indicating that a recurrent
ggesting that a following wave is plausible. For R0 = 1.8 most of the curves overlap
ikely. The black curve indicates the critical vaccination curve used in the analysis.
then predict no further transmission. For R0 ≥1.4, the estimate lies
below the critical immune curve, indicating that a new epidemic
wavewould be possible.We acknowledge that the assumption that
no adults were infected during the ﬁrst wave is unrealistic, but it is
important to note that our method accurately predicts the second
epidemic wave for R0 ≥1.6, for all possible values of natural immu-
nity in the adult population. If R0 =1.4, then as long as less than
30% of the adults were infected during the ﬁrst wave, our method
predicts a new epidemic wave (see panel 2 Fig. 5). Given that most
of the estimates for R0 for pandemic H1N1 place it above 1.2, our
results accurately predicted the second wave of pandemic H1N1
inﬂuenza in London and theWest Midlands during the fall of 2009.
Sensitivity analysis
Weperformedaone-way sensitivity analysis for eachof the con-
tact rates, for the recovery rates in children and adults and for each
of the vaccine efﬁcacy parameters. Since c12 = c21, we performed
sensitivity analysis for the contact rates c11, c12, and c22 only. We
drew values from a uniform distribution of length 0.2 centered
around each value for the given contact rate. Each contact rate was
drawn independently but only the triplets {c11, c12, c22} that satisfy
the following conditions were chosen:- The basic reproduction number obtained by using the contact
rates fell into one of the following intervals: 1.15<R0 <1.25 or
1.35<R0 <1.45 or 1.55<R0 <1.65 or 1.75<R0 <1.85.
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ach vaccine efﬁcacy was drawn independently. The results are quite robust with r
c11 > c12 and c11 > c22 (there are more contacts among children
than among adults and more than between children and adults).
The results for 500 runs for each reproduction number are
hown in Fig. 6. The general trends are quite robust for this sen-
itivity; if R0 =1.2 or R0 =1.4, all of the critical vaccination curves lie
elow the rectangle S. If R0 =1.6 there is some overlap with S, and
or R0 =1.8 the majority of the curves intersect or lie above S.
For the vaccine efﬁcacies, we analyzed the uncertainty by draw-
ng a random number from a uniform distribution of length 0.2
entered around the value used. For each R0, we performed 500
uns. The results are shown in Fig. 7. The trends are very robust
ith respect to these parameters as well.
Finally, we performed sensitivity analysis for the recovery rates
or children and adults. For each recovery rate, we drew a random
umber from a uniform distribution of length 0.2, centered
round the value used. We used only those pairs of recovery
ates for children and adults for which the basic reproduction
umber fell into one of the following intervals: 1.15<R0 <1.25
r 1.35<R0 <1.45 or 1.55<R0 <1.65 or 1.75<R0 <1.85. As shown
n Fig. 8, the results are robust with respect to these
arameters.
iscussionThe approach proposed here, using information derived from
he next generation matrix, provides simple thresholds for the
accine-induced protection and natural immunity needed to pre-
ent further spreadof inﬂuenza, onceawavehaspassed. This canbere taken from a uniform distribution of length 0.2 centered around the values used.
to these parameters.
particularly useful in a situation where most of the parameters are
difﬁcult to determine accurately. Most of the time we only have
ranges of possible values. For example, determining the number
of people infected from reported inﬂuenza illness data is difﬁcult,
given that a fraction of infections are asymptomatic. In addition,
serosurveys can be problematic because of cross reacting antibod-
ies. We have incorporated information about both the naturally
induced immunity and the vaccination induced immunity, and we
have discussed a possible interpretation of this mixture of immu-
nity and its relationship to thenaturally induced immunityonlyand
to the vaccine-induced immunity only. The thresholds proposed
here can be calculated exactly and even if a closed form might not
always be available, symbolic software can help us in interpreting
and using this information. We parametrized our inﬂuenza model
for the pandemic H1N1 and used estimates given by the US Cen-
ters for Disease Control and Prevention (CDC) (Centers for Disease
Control and Prevention, 2010a) and serosurvey data (Ross et al.,
2010) to estimate the level of combined immunity due to vaccina-
tion and previous infection in the United States at the end of the
second wave of pandemic inﬂuenza H1N1 (Fall 2010). Our compu-
tations suggested that for this epidemic, a third wave in the United
States was unlikely if the original R0 was 1.4 or lower, plausible
for the low estimates of mixed immunity if the original R0 was 1.6,
and likely if the original R0 was 1.8 or higher. Our results accu-
rately predicted the absence of a third wave of pandemic inﬂuenza
in the United States during the winter of 2010. It is worth noting
that these results are conservative. This is because the serosur-
vey data was taken during the epidemic and not at the end of it.
Since individuals might take up to several weeks to seroconvert,
30 L. Matrajt, I.M. Longini Jr. / Epidemics 4 (2012) 22–32
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entered around the values used. Only those pairs for which the R0 fell in one of th
.75<R0 < 1.85. The results are very robust with respect to these parameters.
e most probably underestimated the level of immunity in the
opulation. These results were used by the Los Angeles County,
alifornia, Department of Public Health as part of their response to
he pandemic (Chao et al., 2011). Then,we repeated the analysis for
redicting the second wave of pandemic H1N1 in London and the
est Midlands. Using the estimates given in Miller et al. (2010),
ur method suggested that a second wave in London and the West
idlandswas unlikely if R0 =1.2, but likely for all other values of R0.
his shows that ourmethod accurately predicted the occurrence of
he second wave of pandemic inﬂuenza in London and the West
idlands during the fall of 2009.
We used an inﬂuenza model capable of producing multiple
pidemic waves. In order to make our results as general as pos-
ible, we used the simplest structure possible. In particular, we
ssumed that the probability of infection given contact was con-
tant.Modifying this structure for speciﬁc situationswould involve
ore complicated functions for the probability of infection, an
nteresting direction for future work. The approach proposed here
as a number of limitations. First of all, this approach was based
n either being able to explicitly ﬁnd the largest eigenvalue in
losed form or on graphically determining the largest eigenvalue
f the next generation matrix. Obtaining closed forms for a more
omplicated system might be impossible, even with the help of
ymbolic software. While analyzing models with three age groups
s still possible, working with more than three groups is impossi-
le graphically and some other analytical technique would need
o be employed. Also, the model proposed here is very simple.
ven without changing the number of age groups, one can make it
ore realistic. For example, we could allow different probabilitiesrecovery rate was independently taken from a uniform distribution of length 0.2
owing intervals were used: 1.15<R0 < 1.25, or 1.35<R0 < 1.45, or 1.55<R0 < 1.65 or
of infection for children and adults or we could assume differ-
ent recovery rates for asymptomatic and symptomatic individuals.
Given that asymptomatic peoplewill not reduce their level of activ-
ity, one could think of having different contact rates for the two
infected groups. The approach used here to predict the recurrence
of epidemic waves depends heavily on the next generation matrix,
which in turn depends heavily in the contact pattern. Our sensitiv-
ity analysis showed that accurately estimating the contact rates is
important. Our approach ignores the possibility that other factors,
such as time-dependent contact rates, or the dates of school open-
ings might predict new epidemic waves. We did not consider prior
immunity to H1N1,which proved to be enough for protecting older
populations (Centers for Disease Control and Prevention, 2010b).
We did not consider future epidemic waves of H1N1. Finally, we
did not take into account the possible antigenic drift of the virus
that would make previous infected people again susceptible to
some degree and would decrease vaccine efﬁcacy. Incorporating
this feature in our method would allow the possibility of investi-
gating further H1N1 epidemics, like the ones that occurred in the
UK and the rest of Europe during the winter of 2010–2011.
In the model of Hill and Longini (2003), the authors established
thresholds for amodel that does not include asymptomatics or vac-
cine efﬁcacy for pathogenicity. In this sense, the current work is a
natural extension of their model. The SIR model proposed here is
similar to the one proposed by Brauer (2008), but we omitted the
latentperiodandconsideredvaccination insteadof treatment. They
established useful ﬁnal size relations andwe established threshold
conditions. Thus, these results complement each other. While our
model was tailored for inﬂuenza, the methods used here can be
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asily adapted for other acute infectious diseases. For example, this
ethod could be applied to cholera. Cholera is an infectious disease
ith strong seasonality in some countries (Huq et al., 2005), and
mmunity due to natural infection and vaccines wane over a short
eriod of time (Durham et al., 1998; Longini et al., 2002).
We believe that our approach is novel in that we were able
o predict the occurrence (or not) of multiple epidemic waves by
ncorporating information of both the vaccine induced immunity
nd the naturally induced immunity. The method developed here
uggests yet another effect of vaccination. Vaccination not only
irectly protects the vaccinated and indirectly protects the unvac-
inated during the current wave, but it can also help in preventing
ubsequent waves of inﬂuenza.
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ppendix A.
Here, we give the details of the computation of the effective
eproduction number used above. The code can be provided upon
equest. We use the approach given in Diekmann et al. (1990),
rauer et al. (2008) and van den Driessche and Watmough (2002).
et
S10(0) = S10, S11(0) = S11, S20(0) = S20, S21(0) = S21
A10(0) = A10, A11(0) = A11, A20(0) = A20, A21(0) = A21
I10(0) = I10, I11(0) = I11, I20(0) = I20, I21(0) = I21
R10(0) = 0, R11(0) = 0, R20(0) = 0, R21(0) = 0
e the initial conditions for the system (1)–(8) where
S10 + S11 + A10 + A11 + I10 + I11 = N1,
S20 + S21 + A20 + A21 + I21 + I21 = N2
nd A10, A11, I10, I11, A20, A21, I21, I21 are very small positive num-
ers, each close to 0. Deﬁne
0 = (S10, S11, S20, S21,A10,A11, I10, I11,A20,A21, I21, I21,0,0,0,0
If we set A10 =A11 = I01 = I11 =A20 =A21 = I21 = I21 =0, and
10 + S11 =N1, S20 + S21 =N2 the model (1)–(8) has an inﬁnite
umber of disease free equilibria, namely, one per each initial con-
ition given. We linearize the system for the infectious equations
3)–(6) around the disease free equilibrium E0. This gives us the
atrices (as given in Brauer et al., 2008) F and V deﬁned as follows.
= pA ·
⎛
⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜
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where A is given by
A = diag(S10(1 − ), S20(1 − ), S11(1 −  ), S21(1 −  ), S10,
S20, S11 , S21 ),
and V is given by
V = diag(1, 2, 1, 2, 1, 2, 1, 2)
here diag(a, . . ., b) denotes a diagonal matrix with elements a, . . .,
b on the diagonal. The matrix K= FV−1 is called the next generation
matrix. The effective reproduction number Rf is then given by
Rf = (K)
where (K) is the spectral radius of K, that is, the largest eigenvalue
of K in absolute value.
Recall that f1 was deﬁned to be the fraction of vaccinated chil-
dren and f2 was deﬁned to be the fraction of vaccinated adults,
where we assume that vaccination occurred prior to the beginning
of the epidemic. If the number of initial infections is small, we have
S10 ≈ (1 − f1)N1 S11 ≈ f1N1
S20 ≈ (1 − f2)N2 S21 ≈ f2N2.
The matrix K for this particular model has rank 2, allowing us
to conclude that the eigenvalue 0 has multiplicity 6 and that the
remainder eigenvalues can be calculated as the root of the charac-
teristic polynomial P() given by
P() = 2 + 1
12N1N2
(c112N2p(−((1 − f1)N1 + f1N1 )
+m((1 − f1)N1( − 1) + f1N1(  − 1)))
+ c221N1p(−((1 − f2)N2 + f2N2 )
+m((1 − f2)N2( − 1) + f2N2(  − 1))))
+ 1
12N1N2
(−c12c21p2(−((1 − f1)N1 + f1N1 )
+m((1 − f1)N1( − 1) + f1N1(  − 1)))(−((1 − f2)N2
+ f2N2 ) +m((1 − f2)N2( − 1) + f2N2(  − 1)))
+ c11c22p2(−((1 − f1)N1 + f1N1 ) +m((1 − f1)N1( − 1)
+ f1N1(  − 1)))(−((1 − f2)N2 + f2N2 )
+m((1 − f2)N2( − 1) + f2N2(  − 1)))).
The roots of P() were calculated to be
1,2 =
1
212N1N2
{c221N1N2p(f2[m(1 −  −  +  )
+(1 −  )] −m−  +m)
+ c112N1N2p(f1[m(1 −  −  +  ) + (1 −  )] −m
− + m) ± [p24(c12c21 − c11c22)12N1N2(−N1[(1 − f1)
+ f1 ] +mN1[(1 − f1)( − 1) + f1(  − 1)])
× (−N2[(1 − f2) + f2 ] +mN2[(1 − f2)( − 1)
+ f2(  − 1)]) + (c112N1N2[−((1 − f1) + f1 )
+m((1 − f1)( − 1) + f1(  − 1))]
+ c221N1N2[−((1 − f2) + f2 ) +m((1 − f2)( − 1)
+ f (  − 1))])2] 12 }. (11)2
The effective reproduction number Rf is the largest of these
roots, i.e. the one with the positive sign in the square root.
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